SKYRIZI
SIMPONI ARIA® (Golimumab) is an immunosuppressive drug that reduces the body’s inflammation to treat various autoimmune diseases.
SIMPONI ARIA® is manufactured by Janssen Biotech.
Administration and Dosage:
Administration of SIMPONI ARIA follows an induction regimen of intravenous infusions at week 0 and 4 followed by a maintenance infusion every 8 weeks.
Indication:
SIMPONI ARIA® is indicated to treat:
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
Common Side Effects:
The more common side effects of SIMPONI ARIA® include serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis.
More information:
Please read the full Prescribing Information and Medication Guide for SIMPONI ARIA® and discuss any questions you have with your doctor.
HAVE QUESTIONS?
We are happy to help!
